Intraductal carcinoma of the prostate

Intraductal carcinoma of the prostate (IDC-P) is a diagnostic entity characterized by architecturally or cytologically malignant-appearing prostatic glandular epithelium confined to prostatic ducts. Despite its apparent in situ nature, this lesion is associated with aggressive prostatic adenocarcino...

Descripción completa

Detalles Bibliográficos
Autores principales: Szentirmai, Eszter, Giannico, Giovanna Angela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Pacini Editore srl 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8138500/
https://www.ncbi.nlm.nih.gov/pubmed/32202536
http://dx.doi.org/10.32074/1591-951X-5-20
_version_ 1783695824135389184
author Szentirmai, Eszter
Giannico, Giovanna Angela
author_facet Szentirmai, Eszter
Giannico, Giovanna Angela
author_sort Szentirmai, Eszter
collection PubMed
description Intraductal carcinoma of the prostate (IDC-P) is a diagnostic entity characterized by architecturally or cytologically malignant-appearing prostatic glandular epithelium confined to prostatic ducts. Despite its apparent in situ nature, this lesion is associated with aggressive prostatic adenocarcinoma and is a predictor for poor prognosis when identified on biopsy or radical prostatectomy. This review discusses diagnosis, clinical features, histogenesis, and management of IDC-P, as well as current research and controversies surrounding this entity.
format Online
Article
Text
id pubmed-8138500
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Pacini Editore srl
record_format MEDLINE/PubMed
spelling pubmed-81385002021-07-08 Intraductal carcinoma of the prostate Szentirmai, Eszter Giannico, Giovanna Angela Pathologica Review Intraductal carcinoma of the prostate (IDC-P) is a diagnostic entity characterized by architecturally or cytologically malignant-appearing prostatic glandular epithelium confined to prostatic ducts. Despite its apparent in situ nature, this lesion is associated with aggressive prostatic adenocarcinoma and is a predictor for poor prognosis when identified on biopsy or radical prostatectomy. This review discusses diagnosis, clinical features, histogenesis, and management of IDC-P, as well as current research and controversies surrounding this entity. Pacini Editore srl 2020-03-01 /pmc/articles/PMC8138500/ /pubmed/32202536 http://dx.doi.org/10.32074/1591-951X-5-20 Text en © 2020 Copyright by Società Italiana di Anatomia Patologica e Citopatologia Diagnostica, Divisione Italiana della International Academy of Pathology https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed in accordance with the CC-BY-NC-ND (Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International) license. The article can be used by giving appropriate credit and mentioning the license, but only for non-commercial purposes and only in the original version. For further information: https://creativecommons.org/licenses/by-ncnd/4.0/deed.en
spellingShingle Review
Szentirmai, Eszter
Giannico, Giovanna Angela
Intraductal carcinoma of the prostate
title Intraductal carcinoma of the prostate
title_full Intraductal carcinoma of the prostate
title_fullStr Intraductal carcinoma of the prostate
title_full_unstemmed Intraductal carcinoma of the prostate
title_short Intraductal carcinoma of the prostate
title_sort intraductal carcinoma of the prostate
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8138500/
https://www.ncbi.nlm.nih.gov/pubmed/32202536
http://dx.doi.org/10.32074/1591-951X-5-20
work_keys_str_mv AT szentirmaieszter intraductalcarcinomaoftheprostate
AT giannicogiovannaangela intraductalcarcinomaoftheprostate

Ejemplares similares